Natural antimicrobial peptides as a source of new antiviral agents

被引:15
作者
Zakaryan, Hovakim [1 ,2 ]
Chilingaryan, Garri [1 ]
Arabyan, Erik [1 ]
Serobian, Andre [2 ]
Wang, Guangshun [3 ]
机构
[1] NAS, Inst Mol Biol, Lab Antiviral Drug Discovery, Yerevan 0014, Armenia
[2] Denovo Sci CJSC, Yerevan 0033, Armenia
[3] Univ Nebraska Med Ctr, Coll Med, Dept Pathol & Microbiol, 985900 Nebraska Med Ctr, Omaha, NE 68198 USA
关键词
antiviral; design; library; peptide; virus; HERPES-SIMPLEX-VIRUS; HUMAN ALPHA-DEFENSIN; CYCLOTIDE KALATA B1; CATHELICIDIN LL-37; ENVELOPED VIRUSES; DRUG-RESISTANCE; DESIGN; PROTEIN; MECHANISMS; INHIBITORS;
D O I
10.1099/jgv.0.001661
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Current antiviral drugs are limited because of their adverse side effects and increased rate of resistance. In recent decades. much scientific effort has been invested in the discovery of new synthetic and natural compounds with promising antiviral properties. Among this new generation of compounds, antimicrobial peptides with antiviral activity have been described and are attracting attention due to their mechanism of action and biological properties. To understand the potential of antiviral peptides (AVPs), we analyse the antiviral activity of well-known AVP families isolated from different natural sources, discuss their physical-chemical properties, and demonstrate how AVP databases can guide us to design synthetic AVPs with better therapeutic properties. All considerations in this sphere of antiviral therapy clearly demonstrate the remarkable contribution that AVPs may make in conquering old as well as newly emerging viruses that plague humanity.
引用
收藏
页数:14
相关论文
共 132 条
  • [1] Design of a Novel Cyclotide-Based CXCR4 Antagonist with Anti-Human Immunodeficiency Virus (HIV)-1 Activity
    Aboye, Teshome L.
    Ha, Helen
    Majumder, Subhabrata
    Christ, Frauke
    Debyser, Zeger
    Shekhtman, Alexander
    Neamati, Nouri
    Camarero, Julio A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (23) : 10729 - 10734
  • [2] Human Antimicrobial Peptides as Therapeutics for Viral Infections
    Ahmed, Aslaa
    Siman-Tov, Gavriella
    Hall, Grant
    Bhalla, Nishank
    Narayanan, Aarthi
    [J]. VIRUSES-BASEL, 2019, 11 (08):
  • [3] Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections
    Ahmed, Aslaa
    Siman-Tov, Gavriella
    Keck, Forrest
    Kortchak, Stephanie
    Bakovic, Allison
    Risner, Kenneth
    Lu, Timothy K.
    Bhalla, Nishank
    de la Fuente-Nunez, Cesar
    Narayanan, Aarthi
    [J]. ANTIVIRAL RESEARCH, 2019, 164 : 61 - 69
  • [4] Antimicrobial activity, mechanism of action, and methods for stabilisation of defensins as new therapeutic agents
    Amerikova, Meri
    Pencheva El-Tibi, Ivanka
    Maslarska, Vania
    Bozhanov, Stanislav
    Tachkov, Konstantin
    [J]. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2019, 33 (01) : 671 - 682
  • [5] Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity
    Badani, Hussain
    Garry, Robert F.
    Wimley, William C.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2014, 1838 (09): : 2180 - 2197
  • [6] Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37
    Barlow, Peter G.
    Svoboda, Pavel
    Mackellar, Annie
    Nash, Anthony A.
    York, Ian A.
    Pohl, Jan
    Davidson, Donald J.
    Donis, Ruben O.
    [J]. PLOS ONE, 2011, 6 (10):
  • [7] Antimicrobial Peptides: Mechanisms of Action and Resistance
    Bechinger, B.
    Gorr, S. -U.
    [J]. JOURNAL OF DENTAL RESEARCH, 2017, 96 (03) : 254 - 260
  • [8] Bergman P, 2007, CURR HIV RES, V5, P410
  • [9] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [10] Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?
    Brogden, KA
    [J]. NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) : 238 - 250